Piecing the puzzle together: Foreign-born tuberculosis in an immigrant-receiving country

European Respiratory Journal

Volumn 38, Issue 4, 2011, Pages 895-902

  Langlois Klassen, D ^a   Wooldrage, K M ^b   Manfreda, J ^b   Sutherland, K ^a   Ellis, E ^c   Phypers, M ^c   Gushulak, B ^d   Long, R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d Migration Health Consultants Inc   (Canada)

Author keywords

Epidemiology; Foreign born; Immigrants; Tuberculosis

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANADA; CONTROLLED STUDY; FEMALE; HUMAN; IMMIGRANT; IMMIGRATION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; CANADA; CENSUSES; EMIGRANTS AND IMMIGRANTS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TUBERCULOSIS, PULMONARY; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 80053541001     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00196610     Document Type: Article

References (48)

1. Verver S, Veen J. Tuberculosis control and migration. In: Raviglione MC, ed. Reichman and Hershfield's Tuberculosis: A Comprehensive, International Approach. 3rd Edn. New York, Informa Healthcare USA, Inc., 2006; pp. 869-905.
2. Tuberculosis among the foreign-born in Canada. Can Commun Dis Rep 2003; 29: 10-16.
3. Raviglione MC, Sudre P, Rieder HL, et al. Secular trends of tuberculosis in western Europe. Bull World Health Organ 1993; 71: 297-306. (Pubitemid 23200072)
4. Centers for Disease Control and Prevention (CDC). Trends in tuberculosis - United States, 2008. MMWR Morb Mortal Wkly Rep 2009; 58: 249-253.
5. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2008. Geneva, World Health Organization, 2008.
6. Citizenship and Immigration Canada. Annual Report to Parliament on Immigration, 2009. Ottawa,Minister of PublicWorks and Government Services Canada, 2009.
7. Gushulak BD, MacPherson DW. Globalization of infectious diseases: the impact ofmigration. Clin Infect Dis 2004; 38: 1742-1748. (Pubitemid 38781667)
8. MacPherson DW, Gushulak BD. Balancing prevention and screening among international migrants with tuberculosis: population mobility as the major epidemiological influence in low-incidence nations. Public Health 2006; 120: 712-723. (Pubitemid 44111692)
9. Public Health Agency of Canada. Tuberculosis in Canada 2000. Ottawa, Health Canada, 2003.
10. Public Health Agency of Canada. Tuberculosis in Canada 2007. Ottawa, Her Majesty the Queen in Right of Canada, represented by the Minister of Health, 2009.
11. Statistics Canada. Immigration in Canada: a portrait of the foreignborn population, 2006 Census. Ottawa, Minister of Industry, 2007.
12. Das D, Baker M, Venugopal K, et al. Why the tuberculosis incidence rate is not falling in New Zealand. N Z Med J 2006; 119: U2267.
13. Farah MG, Meyer HE, Selmer R, et al. Long-term risk of tuberculosis among immigrants in Norway. Int J Epidemiol 2005; 34: 1005-1011. (Pubitemid 41535544)
14. Creatore MI, Lam M, Wobeser WL. Patterns of tuberculosis risk over time among recent immigrants to Ontario, Canada. Int J Tuberc Lung Dis 2005; 9: 667-672. (Pubitemid 40826160)
15. Cain KP, Benoit SR, Winston CA, et al. Tuberculosis among foreignborn persons in the United States. JAMA 2008; 300: 405-412. (Pubitemid 352040252)
16. Public Health Agency of Canada. Tuberculosis in Canada 2006. Ottawa, Minister of Public Works and Government Services Canada, 2008.
17. Cain KP, Haley CA, Armstrong LR, et al. Tuberculosis among foreign-born persons in the United States - achieving tuberculosis elimination. Am J Respir Crit Care Med 2007; 175: 75-79. (Pubitemid 46105312)
18. Jereb J, Albalak R, Castro KG. The Arden House Conference on Tuberculosis, revisited: perspectives for tuberculosis elimination in the United States. Semin Respir Crit Care Med 2004; 25: 255-269. (Pubitemid 38857279)
19. Statistics Canada. Dimensions: Profile of the Immigrant Population. Ottawa, Minister of Supply and Services Canada, 1989.
20. Statistics Canada. The Nation: Ethnicity, Immigration and Citizenship. Ottawa, Minister of Supply and Services Canada, 1989.
21. Tuberculosis Prevention and Control, Public Health Agency of Canada, Canadian Lung Association/Canadian Thoracic Society. Long R, Ellis E, eds. Canadian Tuberculosis Standards. 6th Edn. Ottawa, Her Majesty the Queen in Right of Canada, represented by the Minister of Health, 2007.
22. Global Tuberculosis Database. Geneva, World Health Organization, 2010.
23. Daniel WW. Biostatistics: A Foundation for Analysis in the Health Sciences. New York, John Wiley & Sons, Inc., 1999.
24. Statistics Canada. Causes of Death: 1986. Vital statistics, Vol. IV, Catalogue 84-203. Ottawa, Minister of Supply and Services Canada, 1988.
25. Statistics Canada. Causes of Death: 1987. Health Reports, Suppl., Vol. 1, No. 1, Catalogue 82-003S. Ottawa, Minister of Supply and Services Canada, 1989.
26. Statistics Canada. Causes of Death: 1988. Health Reports, Suppl. 11, Vol. 2, No. 1, Catalogue 82-003S. Ottawa, Minister of Supply and Services Canada, 1990.
27. Statistics Canada. Causes of Death: 1989. Health Reports, Suppl. 11, Vol. 3, No. 1, Catalogue 82-003S11. Ottawa, Minister of Supply and Services Canada, 1991.
28. Statistics Canada. Causes of Death: 1990. Health Reports, Suppl. 11, Vol. 4, No. 1. Ottawa, Minister of Industry, Science and Technology, 1992.
29. Statistics Canada. CANSIM: Table 102-0504. Deaths and mortality rates, by age group and sex, Canada, provinces and territories, annual. Ottawa, Statistics Canada, 2009. Available at http://estat. statcan.gc.ca/cgi-win/ cnsmcgi.pgm?EST-Fi5ESTAT/English/CII-1-eng.htm&Lang5E&Dir-Rep5ESTAT/ Date last updated: December 15, 2010. Date last accessed: April 15, 2010.
30. Uppaluri A, Naus M, Heywood N, et al. Effectiveness of the immigration medical surveillance program for tuberculosis in Ontario. Can J Public Health 2002; 93: 88-91. (Pubitemid 34552400)
31. Orr PH, Manfreda J, Hershfield ES. Tuberculosis surveillance in immigrants to Manitoba. Can Med Assoc J 1990; 142: 453-458. (Pubitemid 20077832)
32. Statistics Canada. Population Projections for Canada, Provinces and Territories: 2009 to 2036. Ottawa, Minister of Industry, 2010.
33. Kunimoto D, Sutherland K, Wooldrage K, et al. Transmission characteristics of tuberculosis in the foreign-born and the Canadian-born populations of Alberta, Canada. Int J Tuberc Lung Dis 2004; 8: 1213-1220. (Pubitemid 39371834)
34. Lillebaek T, Andersen AB, Bauer J, et al. Risk of Mycobacterium tuberculosis transmission in a low-incidence country due to immigration from high-incidence areas. J Clin Microbiol 2001; 39: 855-861. (Pubitemid 32209691)
35. Borgdorff M, Nagelkerke NJ, Hopewell PC, et al. Transmission of Mycobacterium tuberculosis depending on the age and sex of source cases. Am J Epidemiol 2001; 154: 934-943. (Pubitemid 33069903)
36. Menzies D. Screening immigrants to Canada for tuberculosis: chest radiography or tuberculin skin testing?Can Med Assoc J 2003; 169: 1035-1036. (Pubitemid 37449353)
37. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149: 177-184.
38. Baker CA, Thomas W, Stauffer WM, et al. Serial testing of refugees for latent tuberculosis using the QuantiFERON-Gold In-Tube: effects of an antecedent tuberculin skin test. Am J Trop Med Hyg 2009; 80: 628-633.
39. Schechter M, Zajdenverg R, Falco G, et al. Weekly rifapentine/ isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts. Am J Respir Crit Care Med 2006; 173: 922-926.
40. Hirsch-Moverman Y, Daftary A, Franks J, et al. Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis 2008; 12: 1235-1254.
41. Menzies D, Long R, Trajman A, et al. Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection. Ann Intern Med 2008; 149: 689-697.
42. Sterling TR. New approaches to the treatment of latent tuberculosis. Semin Respir Crit Care Med 2008; 29: 532-541.
43. Nolan CM, Goldberg SV, Buskin SE. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. JAMA 1999; 281: 1014-1018. (Pubitemid 29143893)
44. Fountain FF, Tolley E, Chrisman CR, et al. Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic. Chest 2005; 128: 116-123. (Pubitemid 40994462)
45. Laxminarayan R, Chow J, Shahid-Salles SA. Intervention costeffectiveness: overview of main messages. In: Jamison DT, Breman JG, Measham AR, et al., eds. Disease Control Priorities in Developing Countries. 2nd Edn. New York, Oxford University Press and The World Bank, 2006; pp. 35-86.
46. Schwartzman K, Oxlade O, Barr RG, et al. Domestic returns from investment in the control of tuberculosis in other countries. N Engl J Med 2005; 353: 1008-1020. (Pubitemid 41262335)
47. Wobeser WL, Yuan L, Naus M, et al. Expanding the epidemiologic profile: risk factors for active tuberculosis in people immigrating to Ontario. Can Med Assoc J 2000; 163: 823-828.
48. Long R, Sutherland K, Kunimoto D, et al. The epidemiology of tuberculosis among foreign-born persons in Alberta, Canada, 1989-1998: identification of high risk groups. Int J Tuberc Lung Dis 2002; 6: 615-621. (Pubitemid 36898187)